Management of pouch related symptoms in patients who underwent ileal pouch anal anastomosis surgery for adenomatous polyposis

Table 1 Baseline characteristics of study participants, n (%)

Characteristics	Data
Sex, male	14 (42.4)
Mean age at surgery, years (mean ± SD)	33.2 ± 11.2
Ethnicity, Ashkenazi	11 (33.3)
Genetic diagnosis
FAP	26 (78.7)
Attenuated FAP	3 (9.1)
Polymerase proofreading polyposis	1 (3)
MUTYH	3 (9.1)
mean age at study enrollment, years (mean ± SD)	47.6 ± 12.8
mean time from surgery to enrollment, years (mean ± SD)	14.4 ± 6.9
mean time from pre-treatment endoscopy to clinic visit, months (mean ± SD)	9.6 ± 8.7
mean time from clinic visit to post-treatment endoscopy, months (mean ± SD)	6.5 ± 6.8
Patients undergoing single stage pouch surgery	9 (27.2)
Treatments
Diet	30 (90.9)
Probiotics	21 (63.6)
Loperamide	14 (42.4)
Bismuth	6 (18.1)
Mebeverine	6 (18.1)
Antibiotics	9 (27.2)
5-ASA	5 (15.1)
Topical steroids	1 (3.0)
Patients with desmoid tumor	13 (39.4)

5-ASA: 5-aminosalicylic acid, FAP: Familial adenomatous polyposis.